Technology News and Research

RSS

Using earlier surgical intervention more beneficial to patient with degenerative mitral valve disease

A more aggressive approach to treating degenerative mitral valve disease, using earlier surgical intervention and less invasive techniques, is more beneficial to the patient than "watchful waiting," according to an article in the June 2015 issue of The Annals of Thoracic Surgery.

2 Jun 2015

Researchers develop hybrid tissue-engineered heart valve using patient's own cells

Researchers have created a new heart valve that combines a patient's own cells with metal alloy for a more durable replacement with potentially fewer complications, according to an article in the June 2015 issue of The Annals of Thoracic Surgery.

2 Jun 2015

Researchers identify previously unknown gene mutation that causes achromatopsia

People with achromatopsia, an inherited eye disorder, see the world literally in black and white. Worse yet, their extreme sensitivity to light makes them nearly blind in bright sunlight. Now, researchers at University of California, San Diego School of Medicine and Shiley Eye Institute at UC San Diego Health System have identified a previously unknown gene mutation that underlies this disorder.

2 Jun 2015

Centinel Spine achieves milestone implantation of 20,000 STALIF C cervical integrated interbody devices

Centinel Spine, Inc., the pioneer of spinal Stand-Alone, No-Profile®, Integrated Interbody™ devices has now implanted 20,000 STALIF C cervical Integrated Interbody devices. The STALF C device is implanted during cervical fusion procedures to treat degenerative spinal disorders.

2 Jun 2015

Previously unknown gene mutation linked to inherited eye disorder, achromatopsia

2 Jun 2015

EIB supports research and development of new wireless hearing devices by William Demant

The European Investment Bank (EIB) is supporting the development of new wireless hearing devices and research into more effective acoustic implants by global leader William Demant Holding A/S through a EUR 110 million loan.

2 Jun 2015

Genticel announces positive results of new multivalent HPV therapeutic vaccine based on Vaxiclase platform

Genticel, a French biotechnology company and developer of innovative immunotherapies to prevent cancers caused by the human papillomavirus (HPV), announces today positive preclinical in vivo proof of concept results of GTL002, its multivalent HPV therapeutic vaccine candidate based on the Company’s versatile Vaxiclase platform.

2 Jun 2015

LaunchPad receives exclusive worldwide license for bone adhesive technology from Stryker

LaunchPad Medical, LLC announced today that it has entered into a definitive agreement to license Stryker Corporation's bone adhesive technology, which is based on a unique synthetic biomaterial. Under the terms of the agreement, LaunchPad has received an exclusive worldwide license from Stryker for this technology which is covered by four issued and three pending U.S. patents and includes data from multiple pre-clinical animal studies.

From Stryker 2 Jun 2015

ERC Advanced Grants awarded to seven ETH researchers

Seven ETH Zurich professors have applied successfully for an ERC Advanced Grant, which is worth about CHF 2.5 million. Two of the seven received the coveted award for the second time.

1 Jun 2015

Vaccines - a needle-free future? An interview with Thomas Johnston and Dr. Kees Leenhouts, Mucosis

Scientists recognize that 90% of pathogens actually enter the body through the mucosa and secondly, we have evolved a mucosal defense system that can be used to defend against disease...

1 Jun 2015

Small Business Administration presents prestigious Tibbetts Award to Bexion Pharmaceuticals

Bexion Pharmaceuticals LLC announced that the Small Business Administration (SBA) has awarded the Company the prestigious Tibbetts Award, recognizing Bexion as a "Model of Excellence" for the Federal Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs.

1 Jun 2015

Esperance announces positive results from EP-100 Phase II trial in paclitaxel-resistant ovarian cancer

Esperance Pharmaceuticals Inc. today reported positive results from a Phase II trial of lead candidate EP-100 in ovarian cancer patients resistant to paclitaxel. EP-100 is a targeted membrane-disrupting peptide designed to seek and destroy cancer cells that overexpress luteinizing hormone-releasing hormone (LHRH) receptors on their surfaces. LHRH receptors are over-expressed in a wide range of cancers.

1 Jun 2015

Innovative mini hybrid gamma ray camera improves removal of tumours and lymph nodes

Universities of Leicester and Nottingham to develop mini hybrid gamma ray camera to revolutionise identification and removal of tumours and lymph nodes

1 Jun 2015

FDA clears ADXS-HPV plus epacadostat IND for HPV-associated cervical cancer Phase 2 study

Advaxis, Inc., a clinical-stage biotechnology company developing cancer immunotherapies, today announced the clearance of the Investigational New Drug application by the United States Food and Drug Administration to conduct a Phase 2 study of ADXS-HPV (ADXS11-001) alone or in combination with Incyte Corporation's investigational oral indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor, epacadostat (INCB24360), for the treatment of Stage I-IIIb human papillomavirus (HPV)-associated cervical cancer.

1 Jun 2015

HarkerBIO, AMRI sign collaborative agreement to market structure-based drug discovery services

Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that it has signed a collaborative agreement with biotechnology company HarkerBIO LLC to co-market their structure-based drug discovery services to global pharmaceutical and biotechnology clients.

1 Jun 2015

Asterias reports positive data from AST-VAC1 Phase 2 trial for intermediate, high risk AML

Asterias Biotherapeutics, Inc., a biotechnology company focused on the emerging field of regenerative medicine, today announced positive, new, long-term follow-up data from a Phase 2 clinical trial of AST-VAC1 in patients with intermediate and high risk acute myelogenous leukemia (AML).

1 Jun 2015

Game changing, breakthrough early cancer detection technology presented at ASCO 2015

Anpac Bio-Medical Science Co., Ltd., Chief Executive Officer and Scientist Dr. Chris Yu and the Anpac research team are introducing what the 2015 Nobel Prize Laureate Summit on Biomedical Science (NPLS) organizers published as, "game changing" and "breakthrough" early cancer detection technology research results at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois, May 29 – June 2, 2015.

1 Jun 2015

Scientists develop human cortical spheroids

A patient tormented by suicidal thoughts gives his psychiatrist a few strands of his hair. She derives stem cells from them to grow budding brain tissue harboring the secrets of his unique illness in a petri dish. She uses the information to genetically engineer a personalized treatment to correct his brain circuit functioning. Just Sci-fi? Yes, but...

1 Jun 2015

RI-MUHC researchers receive innovations grants to build technologies to address cancer challenges

"Thanks to the Innovation Fund, our donors to the MGH Foundation and the vision of the Max Pacioretty Foundation, this new specialized MRI will place the Montreal General Hospital as one of the leading level 1 trauma centres in Canada. This valuable piece of healthcare technology will also allow our world-class researchers to better understand brain injuries, which will lead to improved patient diagnosis and treatment," adds Jean-Guy Gourdeau, President and Chief Executive Officer of the Montreal General Hospital Foundation at the MUHC.

1 Jun 2015

Connect.Parkinson national research study achieves enrollment target

The National Parkinson Foundation (NPF) announced today that the Connect.Parkinson national research study, comparing telemedicine care delivered to remote patients from a Parkinson's disease center of excellence to community-based care for Parkinson's disease, has achieved its enrollment target.

1 Jun 2015

Technology News and Research

Using earlier surgical intervention more beneficial to patient with degenerative mitral valve disease

Researchers develop hybrid tissue-engineered heart valve using patient's own cells

Researchers identify previously unknown gene mutation that causes achromatopsia

Centinel Spine achieves milestone implantation of 20,000 STALIF C cervical integrated interbody devices

Previously unknown gene mutation linked to inherited eye disorder, achromatopsia

EIB supports research and development of new wireless hearing devices by William Demant

Genticel announces positive results of new multivalent HPV therapeutic vaccine based on Vaxiclase platform

LaunchPad receives exclusive worldwide license for bone adhesive technology from Stryker

ERC Advanced Grants awarded to seven ETH researchers

Vaccines - a needle-free future? An interview with Thomas Johnston and Dr. Kees Leenhouts, Mucosis

Small Business Administration presents prestigious Tibbetts Award to Bexion Pharmaceuticals

Esperance announces positive results from EP-100 Phase II trial in paclitaxel-resistant ovarian cancer

Innovative mini hybrid gamma ray camera improves removal of tumours and lymph nodes

FDA clears ADXS-HPV plus epacadostat IND for HPV-associated cervical cancer Phase 2 study

HarkerBIO, AMRI sign collaborative agreement to market structure-based drug discovery services

Asterias reports positive data from AST-VAC1 Phase 2 trial for intermediate, high risk AML

Game changing, breakthrough early cancer detection technology presented at ASCO 2015

Scientists develop human cortical spheroids

RI-MUHC researchers receive innovations grants to build technologies to address cancer challenges

Connect.Parkinson national research study achieves enrollment target

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Latest News